MarketPeel
EVP R&D, Chief Medical Officer
Mon, Nov 11, 2024
Nov 11
exercised or converted securities in ALKS
43,058 shares @ $20.03
Increased holdings by +43.40%
Net across this filing: -16.10% (-15,938 shares)
Option Exercise
Sale tied to a same-time option exercise
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-3.05%
1M-8.62%
3M+29.40%
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback